Sale!

Psychopharmacology Update: Series Bundle

$140.00 $130.00

Webinar Series Bundle:
This bundle contains all four parts of the Psychopharmacology Update webinar series. Save $10 with this bundle vs. purchasing individually.

Parts:
A: Antidepressants
B: Psychostimulants
C: Bipolar Medications
D: Schizophrenia, Alzheimer’s, & New Medications

Duration:
Parts A, C, D are 120 minutes including a Q&A
Part B is 90 minutes including a Q&A

Includes (for each webinar):
• A certificate of completion
• The on-demand recording to watch at your convenience
• A handout in PDF format for viewing or self-printing

See below for more information.

A: Antidepressants

Available on-demand with instant access.

B: Psychostimulants

Available on-demand with instant access.

C: Bipolar Medications

Available on-demand with instant access.

D: Schizophrenia, Alzheimer’s, & New Medications

Available on-demand with instant access.

SKU: Psychopharmacology 1 Bundle Categories: , Tags: ,

Description

Parts:
A: Antidepressants
B: Psychostimulants
C: Bipolar Medications
D: Schizophrenia, Alzheimer’s, & New Medications

Duration:
Parts A, C, D are 120 minutes including a Q&A
Part B is 90 minutes including a Q&A

Includes (for each webinar):
• A certificate of completion
• The on-demand recording to watch at your convenience
• A handout in PDF format for viewing or self-printing

Description:
In this series of webinars, we’ll identify the best pharmacological approaches for your clients with mental health and mood disorders; and identify treatment concerns with inappropriate meds or inadequate medication doses. We’ll also discuss helping clients manage unpleasant side effects; strategies to increase medication adherence; and what the latest trends are in the management of Depression, Bipolar, Anxiety, Schizophrenia, ADHD, & Alzheimer’s.

Topics for Part A: Antidepressants
Dsm-5® And Psychotropic Medication Use In Depression
• Neurotransmitters:  the Emotional Signalling Chemicals of the Brain
• Antidepressants: How they are Thought to Work
• Cyclics; SSRIs; SNRIs; Other Common Antidepressants – and Why They are Used
• Side Effects and Risk Factors; Herbals and Depression
• Best Options for Treatment-resistant Depression
Controversy Re: Antidepressants for Children & Adolescents
• The Facts on Antidepressants And Suicide in Children; Medicating Anxiety in Children
• Is “Disruptive Mood Dysregulation Disorder” the New Pediatric Bipolar Disorder?

Topics for Part B: Psychostimulants
•  ADHD Medications
• The Evolution Of Psychostimulants
• What’s New, What’s Old; Stimulants
• Non-stimulants, and Some Surprises

Topics for Part C: Bipolar Medications
The Bipolar Spectrum And Medications
• Medicating Bipolar Disorder; Current “Gold Standard” Treatment And Side Effects
• Anticonvulsant and Antipsychotic Use in Bipolar Disorder; Anticonvulsant Side Effects
• Risks Of Medication Non-compliance
• What’s New And What’s Controversial Concepts In Treating Bipolar Spectrum
The Many Faces Of Anxiety
• How Effective Is Medicating Anxiety? Benzodiazepines; Non-benzodiazepines
• Using Anxiolytics Safely; Side Effects of Anxiolytics; Medications to Treat Insomnia

Topics for Part D: Schizophrenia, Alzheimer’s, & New Medications
Schizophrenia
• How Antipsychotic Medications are Thought to Work; Conventional Antipsychotics
• Second Generation Agents; Antipsychotic Side Effects; Relapse and Non-compliance
Key Things to Know About Alzheimer’s Medications
Looking Ahead: Newly Approved Mental Health Medications

Who Should Attend?:
• Physicians, Psychologists, Mental Health Nurses, Therapists
• Social Workers & Allied Professional Staff in Psychiatric settings
• Primary Care Physicians & Nurses; MH Staff in Community Settings
• Intake & Frontline Staff; Mental Health Managers and Educators
• Mental Health Nurses and Staff in Correctional & Forensic Settings
• Nurses in Pediatric Mental Health and Psychogeriatric Settings

Dr. Anthony Tobia, MD

Having trained in a dual residency in Internal Medicine and Psychiatry at West Virginia University, Dr. Tobia currently holds titles of Professor of Psychiatry and Clinical Professor of Internal Medicine at Rutgers Robert Wood Johnson Medical School. Dr. Tobia has dual appointments in the Division of General Internal Medicine and Department of Psychiatry where he serves as the Vice Chair of Education. Dr. Tobia is also certificated by the Board of Psychosomatic Medicine (2010) and is currently the Director of the Division of Consultation Psychiatry at Robert Wood Johnson Barnabas Health in New Brunswick, NJ.

Dr. Tobia’s educational interests include the merging of popular culture and the field of Psychiatry. In addition to the curriculum he developed at RWJMS, he directs the monthly Participatory Cinema at the Rutgers Center of Alcohol Studies; is a blogger for Psychology Today; hosts a continuing education webpage on MyCME; and provides a psychopharmacology seminar series for PESI, Inc. His various innovative teaching approaches including six that are registered in the Office of Research Commercialization at Rutgers University.